DK507079A - Svaekket stamme af infektioes katteperitonitisvirus,fremgangsmaade til dens fremstilling og vaccine indeholdende den svaekkedevirusstamme - Google Patents

Svaekket stamme af infektioes katteperitonitisvirus,fremgangsmaade til dens fremstilling og vaccine indeholdende den svaekkedevirusstamme

Info

Publication number
DK507079A
DK507079A DK507079A DK507079A DK507079A DK 507079 A DK507079 A DK 507079A DK 507079 A DK507079 A DK 507079A DK 507079 A DK507079 A DK 507079A DK 507079 A DK507079 A DK 507079A
Authority
DK
Denmark
Prior art keywords
virus
stream
weakless
weakly
procedure
Prior art date
Application number
DK507079A
Other languages
English (en)
Inventor
B Fishman
L M Hitchcock
K J O'reilly
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK507079A publication Critical patent/DK507079A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/819—Viral vaccine for feline species, e.g. cats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK507079A 1978-11-30 1979-11-29 Svaekket stamme af infektioes katteperitonitisvirus,fremgangsmaade til dens fremstilling og vaccine indeholdende den svaekkedevirusstamme DK507079A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7846603 1978-11-30

Publications (1)

Publication Number Publication Date
DK507079A true DK507079A (da) 1980-05-31

Family

ID=10501422

Family Applications (1)

Application Number Title Priority Date Filing Date
DK507079A DK507079A (da) 1978-11-30 1979-11-29 Svaekket stamme af infektioes katteperitonitisvirus,fremgangsmaade til dens fremstilling og vaccine indeholdende den svaekkedevirusstamme

Country Status (11)

Country Link
US (1) US4571386A (da)
EP (1) EP0011864B1 (da)
JP (1) JPS5576819A (da)
AT (1) ATE1070T1 (da)
AU (1) AU5329279A (da)
DE (1) DE2962920D1 (da)
DK (1) DK507079A (da)
ES (1) ES8107025A1 (da)
HU (1) HU181993B (da)
NZ (1) NZ192270A (da)
ZA (1) ZA796476B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines
US5043157A (en) * 1986-02-06 1991-08-27 Cornell Research Foundation, Inc. Feline infectious peritonitis vaccine and method of preparation
WO1987004624A1 (en) * 1986-02-06 1987-08-13 Schering Corporation Feline infectious peritonitis vaccine
IL87911A0 (en) * 1987-10-01 1989-03-31 Norden Lab Inc Vaccine for protection of cats against feline infectious peritonitis
US5667785A (en) * 1987-10-01 1997-09-16 Pfizer Inc. Vaccine for protection of cats against feline infectious peritonitis
CA2005291C (en) * 1988-12-30 1999-01-26 Beverly Dale Feline infectious peritonitis virus diagnostic tools
NZ240558A (en) 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
CA2128698A1 (en) * 1992-02-18 1993-08-19 Richard G. Olsen Feline infectious peritonitis vaccine and method of preparation
US20040063093A1 (en) * 1992-04-08 2004-04-01 Pfizer, Inc. Recombinant feline coronavirus S proteins
TW377373B (en) * 1993-09-22 1999-12-21 Wyeth Corp Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
CN114874997B (zh) * 2022-05-26 2023-05-23 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 猫杯状病毒

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL300960A (da) * 1962-11-27
GB1177635A (en) * 1966-02-18 1970-01-14 Wellcome Found Cell Stains.
GB1286250A (en) * 1968-10-08 1972-08-23 Wellcome Found Heteroploid cell lines
US3892627A (en) * 1973-06-04 1975-07-01 Rohm & Haas Feline panleukopenia vaccine
US4287178A (en) * 1974-03-25 1981-09-01 Pitman-Moore, Inc. Feline rhinotracheitis vaccine and production and use thereof
GB1471262A (en) * 1974-03-25 1977-04-21 C Vet Ltd Virus growth
GB1492930A (en) * 1974-10-31 1977-11-23 Afg Ltd Virus growth
US3937812A (en) * 1974-11-21 1976-02-10 Pitman-Moore, Inc. Feline calicivirus vaccine and production thereof
US3944469A (en) * 1974-11-21 1976-03-16 Pitman-Moore, Inc. Feline calicivirus vaccine and production thereof
DE2602478C3 (de) * 1976-01-23 1980-10-09 Behringwerke Ag, 3550 Marburg Impfstoff gegen die Panleukopenie der Feliden
US4031204A (en) * 1976-03-30 1977-06-21 Norden Laboratories, Inc. Feline viral rhinotracheitis vaccine and combination feline viral rhinotracheitis-calicivirus vaccine prepared therefrom
US4195130A (en) * 1978-04-20 1980-03-25 Cornell Research Foundation, Inc. Propagation of feline infectious peritonitis virus in tissue cultures
US4293653A (en) * 1979-04-12 1981-10-06 Horzinek Marian C Method for propagating feline infectious peritonitis virus
US4303644A (en) * 1979-10-16 1981-12-01 Norden Laboratories, Inc. Feline infectious peritonitis virus vaccines

Also Published As

Publication number Publication date
NZ192270A (en) 1983-05-31
EP0011864B1 (en) 1982-05-19
ZA796476B (en) 1981-07-29
US4571386A (en) 1986-02-18
EP0011864A1 (en) 1980-06-11
ATE1070T1 (de) 1982-06-15
JPS5576819A (en) 1980-06-10
AU5329279A (en) 1980-06-05
ES486442A0 (es) 1980-12-16
DE2962920D1 (en) 1982-07-08
HU181993B (en) 1983-11-28
ES8107025A1 (es) 1980-12-16

Similar Documents

Publication Publication Date Title
KR900001382A (ko) 연속 셀라인에서의 ibdv생성
DK507079A (da) Svaekket stamme af infektioes katteperitonitisvirus,fremgangsmaade til dens fremstilling og vaccine indeholdende den svaekkedevirusstamme
ES548397A0 (es) Un metodo para producir normas orales frente a virus de hepatitis-b.
Osterhaus et al. Isolation of a virus closely related to feline panleukopenia virus from dogs with diarrhea
ATE7855T1 (de) Herstellung von virusantigenen.
US4303644A (en) Feline infectious peritonitis virus vaccines
KR100531491B1 (ko) 백신으로서 소 호흡 코로나바이러스
Kono et al. An epidemic of Getah virus infection among racehorses: properties of the virus
DE3888290D1 (de) Mutanten des infektiösen bovinen Rhinotracheitisvirus, Vakzine die sie enthalten, Verfahren zu ihrer Herstellung und ihrer Verwendung.
Cubitt et al. Propagation and preliminary characterization of a chicken candidate calicivirus
US2965544A (en) Tissue culture propagated canine distemper virus and vaccine thereof
AU4862085A (en) Triply cloned hepatitis a live attenuated virus
DK506979A (da) Vaccine mod infektioes katte-peritonitis og fremgangsmaade til dens fremstilling
AU6258480A (en) Prep" of influenza virus strains and vaccines
Imagawa Propagation of rinderpest virus in suckling mice and its comparison to murine adapted strains of measles and distemper
ATE4282T1 (de) Verfahren zur herstellung von toxoplasmenbereitungen fuer die toxoplasmosediagnose und die so hergestellten bereitungen.
GB1016586A (en) Vaccine for immunization of dogs against distemper and hepatitis contagiosa canis
SHIMAZU RESEARCH ON DENGUE IN TISSUE CULTURE: II. Further Observations on Virus-Tissue Culture Affinity
SU734279A1 (ru) Вакцинный штамм в вируса N 5 вгнки
Gillett et al. The laboratory transmission of yellow fever by the mosquito Aedes (Stegomyia) strelitziae Muspratt
Forsyth Identification of respiratory syncytial virus antigens by agar gel diffusion and immunoelectrophoresis
FR2290220A2 (fr) Nouveau vaccin antirabique
ATE48948T1 (de) Staemme des rinderdiarrhoeevirus, ihre herstellung und diese enthaltende vakzine.
Hessami et al. A new outbreak of rinderpest in Iran
DK151086A (da) Klebsiella-vaccine paa basis af rensede kapselformede polysaccharider og fremgangsmaade til fremstilling af en saadan vaccine

Legal Events

Date Code Title Description
ATS Application withdrawn